Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis
NCT ID: NCT03387423
Last Updated: 2024-10-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1459 participants
OBSERVATIONAL
2017-11-02
2023-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)
NCT01565122
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis
NCT04721808
An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice
NCT01474291
Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients
NCT04079920
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
NCT02281552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tofacitinib
Patients who are started on Tofacitinib treatment according to the drug label
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Confirmed Diagnosis of Rheumatoid Arthritis by rheumatologist
Patient is eligible for Tofacitinib treatment according to Summary of Product Characteristics (SmPC)
Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
Exclusion Criteria
Receipt of any investigational drug within 3 months before study inclusion
Patients who have received any previous treatment with Tofacitinib or other JAK inhibitors
Patients who are investigational site staff members or patients who are Pfizer employees directly involved in the conduct of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Private Praxis
Düsseldorf, North Rhine-Westphalia, Germany
Private Practice
Zschopau, Saxony, Germany
Private Practice Kupka
Altenburg, , Germany
Private Practise Boehm
Altenholz, , Germany
Private Practice Marycz
Amberg, , Germany
Private Practice Fuchs
Augsburg, , Germany
private practise Gause
Bad Bramstedt, , Germany
ACURA Kliniken Rheinland-Pfalz AG
Bad Kreuznach, , Germany
MFZ Medizinisches Forschungszentrum Weserbergland
Bad Pyrmont, , Germany
Private Practice Manger
Bamberg, , Germany
Private Practice Ochs
Bayreuth, , Germany
Private Practice Schmitt-Haendle
Bayreuth, , Germany
Private Practice
Bayreuth, , Germany
Ambulantes Gesundheitszentrum der Charité
Berlin, , Germany
Private Practice Bozorg
Berlin, , Germany
Private Practice Brandt-Juergens
Berlin, , Germany
Privat Practice Remstedt
Berlin, , Germany
private practise Herzberg
Berlin, , Germany
Private Practice Seifert
Berlin, , Germany
Private Practice Zinke
Berlin, , Germany
Private Practice Thiele
Berlin, , Germany
Immanuel Klinikum Bernau
Bernau, , Germany
Private Practise
Braunschweig, , Germany
MED Bayern OST GmbH
Burghausen, , Germany
Private Practice Lorenz
Chemnitz, , Germany
Private Practice Baerlecken
Cologne, , Germany
Private Practice Kirrstetter
Deggendorf, , Germany
Kreiskranenhaus Demmin GmbH
Demmin, , Germany
Private Practice Menne
Dortmund, , Germany
Private Practice Luethke
Dresden, , Germany
Private Practice Fischer
Dresden, , Germany
private practise Pech
Eberswalde, , Germany
Private Practice Steinmueller
Ehringshausen, , Germany
Asklepios MVZ Nord SH GmbH, c/o AK St. Georg
Elmshorn, , Germany
Private Practice Kaestner
Erfurt, , Germany
Private Practice Koch
Erfurt, , Germany
Private Practice Haeckel
Frankenberg, , Germany
Private Practice Mueller
Freiberg, , Germany
SRH Krankenhaus Waltershausen-Friedrichroda GmbH
Friedrichroda, , Germany
Private Practice Abahji
Germering, , Germany
Private Practice Sensse
Gifhorn, , Germany
Private Practice Holst
Glaisin, , Germany
Private Practice Zeh
Göppingen, , Germany
Private Practice Semmler
Güstrow, , Germany
private practise Kühne
Haldensleben I, , Germany
Private Practice Liebhaber
Halle, , Germany
Private Practice Dahmen
Hamburg, , Germany
private practise Aries
Hamburg, , Germany
Private Practice Stille
Hanover, , Germany
private practise Heilig
Heidelberg, , Germany
private practise Wernicke
Hohen Neuendorf, , Germany
Private Practice Kremers
Jülich, , Germany
Medius Kliniken gGmbH
Kirchheim unter Teck, , Germany
Kreiskrankenhaus Langenau
Langenau, , Germany
Private Practice Hamann
Leipzig, , Germany
Private Practice Schwarze
Leipzig, , Germany
Private Practice Kudela
Magdeburg, , Germany
private practise Sieburg
Magdeburg, , Germany
Private Practice Rossbach
Mansfeld, , Germany
Private Practice Harmuth
Marktredwitz, , Germany
Private Practice Worsch
Mühlhausen, , Germany
Private Practice Krueger
München, , Germany
Private Practice Raub
Münster, , Germany
Praxis Dr.med. Holger Krauel Facharzt für Innere Medizin und Rheumatologie
Naumburg, , Germany
Private Practice Berger
Naunhof, , Germany
Private Practise
Neubrandenburg, , Germany
Private Practice Volberg
Neuss, , Germany
MCN Medic Center Nuernberg GmbH
Nuremberg, , Germany
Private Practice Goettl
Passau, , Germany
Private Practice Graessler
Pirna, , Germany
Private Practice Baumann
Plauen, , Germany
Knappschaftsklinikum Soor, Klinik fuer Rheumatologie und Klinische Immunologie
Püttlingen, , Germany
Private Practice Wassenberg, Koehler, Weier
Ratingen, , Germany
Private Practice Richter
Rostock, , Germany
private practise Biewer
Saarbrücken, , Germany
MVZ Dialysezentrum Schweinfurt
Schweinfurt, , Germany
Private Practice Moebius
Schwerin, , Germany
Private Practice
Schwerin, , Germany
private practise Ständer
Schwerin, , Germany
Private Practice Melzer
Seesen, , Germany
MVZ Klinikum Straubing
Straubing, , Germany
Private Practice
Templin, , Germany
Private Practice Pyra
Torgelow, , Germany
Private Practice Haas
Tübingen, , Germany
Klinik an der Weissenburg GmbH
Uhlstaedt-Kirchhasel, , Germany
Private Practice Rinaldi
Ulm, , Germany
Private Practice Woerth
Wiesbaden, , Germany
Klinikverbund St. Antonius und St. Josef GmbH
Wuppertal, , Germany
Rheuma Praxis Barmen Dres. med. Demirel / Hruschka
Wuppertal, , Germany
Private Practice Fricke-Wagner
Zwickau, , Germany
Private Practice Alliger
Zwiesel, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESCALATE-RA
Identifier Type: OTHER
Identifier Source: secondary_id
A3921302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.